Frank Su is the founder of TCR Cure. TCR Cure has raised $47M in total funding. Latest round: Series C. Based in Hong Kong SAR.
Frank Su is the CEO and Co-founder of TCR Cure. He is a veteran entrepreneur and biotech investor with extensive experience in clinical development and business development. TCR Cure specializes in cellular immunotherapy, aiming to become a global leader in the field.
Full founder directory · Investor directory · Company funding database · Fundraising library